Three major research goals in the Parissenti lab: understand, identify and create.

Dr. Amadeo Parissenti and his team’s first goal is to better understand how specific classes of chemotherapy drugs (anthracyclines and taxanes) halt the growth or kill breast tumour cells. Their second goal is to identify mechanisms by which breast cancer cells resist the action of these chemotherapy agents. This knowledge is identifying new approaches to improve the efficacy of chemotherapy. The final goal of the group is to create a diagnostic tool to distinguish between chemotherapy-sensitive tumours and those that are drug-resistant.

Dr. Parissenti began his post secondary education at the University of Guelph, completing his Bachelor of Sciences in Biochemistry. He was awarded his PhD in Biochemistry from York University. He also completed two postdoctoral research fellowships in medicine, the first at the Harvard Medical School & Joslin Diabetes Center and the second at the Banting and Best Department of Medical Research at the University of Toronto.

He is currently a Professor in the Department of Chemistry and Biochemistry at Laurentian University as well as a Professor in the Division of Medical Sciences at the Northern Ontario School of Medicine. Dr. Parissenti is also an Assistant Professor in the Division of Oncology with the Department of Medicine at the University of Ottawa.

Promising find by cancer research team – The Sudbury Star